Endoscopy 2021; 53(S 01): S183-S184
DOI: 10.1055/s-0041-1724756
Abstracts | ESGE Days
ESGE Days 2021 Digital poster exhibition

The Acute Effect of Biological Agents used in Inflammatory Bowel Disease on ECG Parameters

B Çavuş
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
,
A Çiftcibaşı Örmeci
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
,
D Kaya
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
,
N Alizade
2   İstanbul Universitesi İstanbul Tıp Fakültesi, Internal Medicine, İstanbul, Turkey
,
A Yakut
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
,
Z İmanov
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
,
Şenkal İV
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
,
E Çevik
3   İstanbul Universitesi İstanbul Tıp Fakültesi, Cardiology, İstanbul, Turkey
,
A Atıcı
3   İstanbul Universitesi İstanbul Tıp Fakültesi, Cardiology, İstanbul, Turkey
,
K Demir
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
,
F Beşışık
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
,
S Kaymakoğlu
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
,
F Akyuz
1   İstanbul Universitesi İstanbul Tıp Fakültesi, Gastroenterology, İstanbul, Turkey
› Author Affiliations
 

Aims Ulcerative colitis and Crohn’s disease are chronic inflammatory bowel diseases.The effect of inflammation on atrial and ventricular conduction defects is known,however,different results have been obtained in many studies on the effectiveness of anti TNFs and biological agents on cardiac conduction. We aimed to evaluate the effects of biological agents on atrial and ventricular conduction in IBD through ECG parameters.

Methods A total of 99 IBDs with UC(38 patients) and Crohn’s disease(61 patients) were included in this prospective study.Patients followed under infliximab or vedolizumab therapy for the treatment of IBD were included. Twelve-lead ECGs were obtained for all participants and ECG parameters QT,QTc,Tpe,Tpe/QT,Tpe/QTc,QRS,Pmax,Pmin,PWD were evaluated before and after the infusion for all patients.

Results

Tab. 1

N

Mean

Std.Dev.

p

QT

Before infusion

<,001

n

99

Mean

375,2525

Std.Dev

27,70115

After infusion

n

99

Mean

411,3434

Std.Dev

28,13893

QTd

Before infusion

,027

n

99

Mean

22,5657

Std.Dev

13,36471

After infusion

n

99

Mean

27,4949

Std.Dev

18,04946

Tpe/QT

Before infusion

<,001

n

99

Mean

,2395

Std.Dev

,02769

After infusion

n

99

Mean

,2654

Std.Dev

,03233

Tpe/QTc

Before infusion

<,001

n

99

Mean

,2112

Std.Dev

,02526

After infusion

n

99

Mean

,2468

Std.Dev

,02941

A total of 99 IBDs from 61 men (61.6 %) were included in our study. Mean age of the patients was 46.48 +/- 23.8 years. The mean age of the disease was 17.5+/-13.17 years. 90.6 % of the patients were using infliximab and 9.4 % vedolizumab. The mean duration of biological agent use was 44.77 +/- 34.75 months. 12.1 % of the patients had a history of using a different biological agent before. When the laboratory findings of the patients were examined, calcium was 9.41 +/- 0.4mg/dl, and the CRP level was 8.23 +/- 13.6 mg/dl. It was found that the QT, QTc, Tpe, Tpe/QT, Tpe/QTc/QTd values of the patients, evaluated before and after the infusion, were statistically significantly prolonged after the infusion ([Table 1]). When this difference in ECG parameters was examined in terms of gender, age, IBD type and the effect of immunosuppressives used, it was not found statistically significant.

Conclusions It was found that QT,QTc,Tpe,Tpe/QT,Tpe/QTc/QTd parameters,which are considered as ventricular repolyirization indicators,were prolonged after the application of antiTNF and vedolizumab,however,there was no statistically significant difference in Pmax,Pmin,PWD,which are accepted as atrial conduction parameters.

Citation: Çavuş B, Çiftcibaşı Örmeci A, Kaya D etal. eP261 THE ACUTE EFFECT OF BIOLOGICAL AGENTS USED IN INFLAMMATORY BOWEL DISEASE ON ECG PARAMETERS. Endoscopy 2021; 53: S183.



Publication History

Article published online:
19 March 2021

© 2021. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany